| 2025-12-05 | UPC_CFI_775/2025 | Nordic-Baltic RD | Application RoP262A | Prozessual | Nur prozessual | The Nordic-Baltic Regional Division stayed the cost proceedings between Edwards Lifesciences and Meril pending the outcome of EPO Board of Appeal opposition proceedings against EP 3 769 722, and provisionally ordered confidentiality obligations by mutual agreement of the parties. |
| 2025-12-05 | UPC_CFI_492/2024 | Copenhagen LD | Application for preserving evidence pursuant to RoP192 | Beweis | outcomeName.other | The Copenhagen Local Division (in Danish) imposed penalty payments of EUR 67,500 on HGSystem ApS and associated entities for delayed compliance with a preservation of evidence order in proceedings concerning EP 4 238 202 B1. The defendants had failed to provide access codes and login information for financial systems, email accounts, and a seized computer for 36 days. The Court found penalties of EUR 5,000 per day appropriate for the first 18-day period and EUR 2,500 per day for the subsequent 18 days, acknowledging that penalties also serve a punitive function even where the obligation has since been fulfilled. Costs deferred to the main proceedings. |
| 2025-09-02 | UPC_APP_35269/2025 | Nordic-Baltic RD | Generic application | Kosten | Nur prozessual | Order of the Nordic-Baltic Regional Division in Edwards Lifesciences v Meril Life Sciences et al. (EP 3 769 722) on a request for rectification of the decision on the merits of 21 July 2025. The prior decision on the merits found the patent invalid as granted but upheld it as amended, and found infringement of the amended patent. The operative part of that decision ordered the defendants to bear 100% of Edwards' costs in the infringement action and 75% of Edwards' costs in the revocation counterclaim proceedings. The defendants requested rectification to add an obligation on Edwards to bear 25% of the defendants' costs in the revocation proceedings. The rectification request is the subject of this order. |
| 2025-08-25 | ORD_35448/2025 | Hamburg LD | Generic Order | Prozessual | Nur prozessual | The Hamburg Local Division ruled that authority to represent a defendant in provisional measures proceedings does not automatically extend to receiving service of a statement of claim in subsequent infringement proceedings, and that service on non-EU defendants must follow Rule 274 RoP. |
| 2025-03-03 | UPC_CFI_492/2024 | Copenhagen LD | Application for preserving evidence pursuant to RoP192 | Beweis | Nur prozessual | Order by the Copenhagen Local Division in preservation of evidence proceedings. The court ruled that the supplementary IT expert report from the evidence preservation procedure may be disclosed to the parties' representatives under confidentiality obligations. The court declined to impose penalty payments at that stage. Costs deferred to main proceedings. |
| 2025-02-27 | UPC_APP_7494/2025 | Nordic-Baltic RD | Application Rop 265 | Prozessual | Vergleich | The Nordic-Baltic Regional Division declared provisional measures proceedings between Fapa Vital AG and Valentis Baltic UAB concerning EP1978949 closed following the applicant's withdrawal after a settlement, ordered 60% reimbursement of court fees under R.370.9(b)(i) RoP, and declined to issue a cost decision as agreed by the parties. |
| 2025-02-17 | UPC_CFI_527/2024 | Nordic-Baltic RD | Application for preserving evidence pursuant to RoP192 | — | Zurückgenommen | Nordic-Baltic Regional Division declared the evidence preservation proceedings closed following Imbox Protection's withdrawal of its application after being convinced that the defendants do not infringe EP 2 276 862. As the unsuccessful party, Imbox was ordered to reimburse each defendant (Brunngård Group AB and Footbridge Group AB) SEK 225,000 in legal costs. The ceiling for recoverable costs applies as a joint ceiling regardless of number of defendants. |
| 2025-01-21 | UPC_APP_33375/2024 | Nordic-Baltic RD | Application RoP262.1 (b) | Prozessual | Abgewiesen | Nordic-Baltic Regional Division judge-rapporteur closed proceedings following withdrawal of seven public access applications (R. 262.1(b) RoP) by the applicant (an individual acting also on behalf of SWAT Medical AB) in Edwards Lifesciences Corporation v. Meril et al. proceedings. Meril Life Sciences PVT Limited's request for cost reimbursement (EUR 17,168.70) was rejected: Art. 69 UPCA does not apply to proceedings on public access requests because (i) the Enforcement Directive's cost principle does not extend to such requests, (ii) no ceiling for recoverable costs has been set for access proceedings, and (iii) parties to the main proceedings are merely consulted, not 'parties' in the access sub-proceedings. |
| 2025-01-20 | UPC_APP_68693/2024 | Nordic-Baltic RD | Application Rop 265 | Prozessual | Zurückgenommen | The Nordic-Baltic Regional Division declared the proceedings closed following the mutual withdrawal of Abbott Diabetes Care's infringement action and Dexcom's counterclaim for revocation (both relating to EP 3 977 921). Both parties consented to withdrawal with no cost decision requested or made. |
| 2025-01-20 | UPC_APP_68369/2024 | Nordic-Baltic RD | Application Rop 265 | Prozessual | Zurückgenommen | The Nordic-Baltic Regional Division permitted the withdrawal of Abbott Diabetes Care Inc.'s infringement action (ACT_588346/2023) and Dexcom's counterclaim for revocation (CC_14848/2024) in Abbott v Dexcom proceedings (UPC 430/2023, EP 3 977 921). Both parties consented to each other's withdrawals and agreed that no costs order would be made. The Court declared the proceedings closed. |
| 2024-12-11 | ORD_65290/2024 | Nordic-Baltic RD | Generic Order | Prozessual | Nur prozessual | Nordic-Baltic Regional Division (full panel) order dismissing defendants' request to stay the main infringement proceedings pending EPO opposition proceedings concerning EP 3 769 722. The Court of Appeal had previously set aside an earlier stay dismissal and referred back for reconsideration under R. 295(a) RoP. On reconsideration, the panel dismissed the stay request again in the Meril/Edwards heart valve case (Edward Lifesciences v Meril entities). The request to stay pending Central Division revocation counterclaim was also refused. |
| 2024-10-07 | ORD_55063/2024 | Nordic-Baltic RD | Generic Order | Prozessual | Nur prozessual | Nordic-Baltic Regional Division (judge-rapporteur Kai Härmand) preliminary/case management order in Abbott Diabetes Care Inc.'s infringement action against Dexcom Inc. and Dexcom International Limited concerning EP 3 977 921 (a continuous glucose monitoring patent). The order addresses multiple pending applications including Abbott's R. 190 application to communicate information (partially dismissed following Paris LD precedent), Abbott's R. 191 application (found admissible but not justified), Abbott's application to change the statement of claim, Dexcom's request for security for legal costs, and sets procedural deadlines and oral hearing preparation steps. |
| 2024-09-18 | UPC_APP_33494/2024 | Nordic-Baltic RD | Application RoP262.1 (b) | Prozessual | Nur prozessual | Procedural order of the Nordic-Baltic Regional Division (full panel) on the same anonymized applicant's third parallel request for access to pleadings and evidence under Rule 262.1(b) RoP in the Edwards Lifesciences v. Meril proceedings (EP 2 628 464). Filed as App_33494/2024, this order applies the same legal principles on public access as the companion orders in App_33316/2024 and App_33493/2024, with substantially identical headnotes and analysis. |
| 2024-09-18 | UPC_APP_33493/2024 | Nordic-Baltic RD | Application RoP262.1 (b) | Prozessual | Nur prozessual | Procedural order of the Nordic-Baltic Regional Division (full panel) on the same anonymized applicant's request for access to pleadings and evidence under Rule 262.1(b) RoP in the Edwards Lifesciences v. Meril proceedings (EP 2 628 464). This is a parallel order filed in the counterclaim proceedings under App. 33493/2024, applying the same legal principles as App_33316/2024. The headnotes and legal analysis concerning public access under Art. 45 UPCA are substantially identical to the order in App_33316/2024. |
| 2024-09-18 | UPC_APP_33316/2024 | Nordic-Baltic RD | Application RoP262.1 (b) | Prozessual | Nur prozessual | Procedural order of the Nordic-Baltic Regional Division (full panel) on an anonymized applicant's request for access to pleadings and evidence under Rule 262.1(b) RoP in the Edwards Lifesciences v. Meril infringement proceedings (EP 2 628 464). The court set out important headnotes on public access: Art. 45 UPCA establishes a principle of openness of UPC proceedings including written procedure, and if an applicant has provided a credible explanation for seeking access, the application should be approved unless confidentiality is necessary. The court addressed whether the applicant's stated interest was sufficient to justify granting access. |
| 2024-08-20 | UPC_APP_14299/2024 | Nordic-Baltic RD | Generic application | Prozessual | Nur prozessual | Order by Nordic-Baltic Regional Division (UPC_CFI_380/2023, 20 August 2024) dismissing Meril defendants' application to stay infringement proceedings pending EPO opposition on EP 3 769 722 (transcatheter heart valve). The court clarified that R. 295(a) RoP and Art. 33(10) UPCA allow a discretionary stay during written procedure only if a rapid EPO decision is expected; R. 118.2(b) RoP applies only in the oral procedure phase. |
| 2024-08-20 | UPC_APP_14061/2024 | Nordic-Baltic RD | Generic application | Prozessual | Nur prozessual | Procedural order from the Nordic-Baltic Regional Division (UPC_CFI_380/2023) dismissing Meril entities' application for security for costs against Edwards Lifesciences in an infringement action concerning EP 3 769 722. The Court held that the mere fact that the claimant is located in the United States does not justify ordering security for costs, as this would constitute an unjustified restriction of the right to an effective remedy; the risk of unenforceability in the US was deemed insufficient. |
| 2024-08-16 | UPC_APP_43606/2024 | Nordic-Baltic RD | Generic application | Prozessual | Nur prozessual | The Nordic-Baltic Regional Division issued a procedural order setting the timetable for resumption of Edwards Lifesciences' infringement action against Meril entities after a stay pending EPO Technical Board of Appeal decision in T0308/23 concerning EP 2 628 464. |